DRTS Stock Analysis Today

Updated Nov 19, 2026 · trends, key levels, insider activity and news

$11.31-$0.70 (-5.83%)close Nov 19, 2026

Is DRTS bullish or bearish today?

Daily trend: Downtrend (confirmed) — turns up above $14.50

SEPT signal: Expanding · Consolidating

Research grade: B · fair value $9.23 (+32.8%)

DRTS trend by timeframe

DailyDowntrend (confirmed)
4 hourExpanding
1 hourStrong Bearish
15 minBullish
5 minBullish

Trends are calculated from price structure and update during market hours.

DRTS support and resistance levels

Resistance (above)

$12.674 touches

$13.561 touches

$14.4312 touches

Support (below)

$10.966 touches

$9.217 touches

$7.1711 touches

Upside zones: $15.71 / $16.36 / $17.01

See all levels on the live chart →

Insider and institutional activity

Insiders

Sell

30-day buys / sells

0 / 0

30-day net

—

Hedge fund holders

98

Latest DRTS news and filings

  • ProductBenzinga

    Alpha Dart Therapy clears tumors in five brain cancer patients

    A treatment called Alpha Dart Therapy produced complete tumor clearance in five patients with brain cancer. The report describes the therapy's effect in these patients.

  • ProductBenzinga

    Alpha Tau says Alpha DaRT worked in all eight brain cancer patients treated

    Alpha Tau reported that its Alpha DaRT therapy was deliverable in every one of the eight people with recurring glioblastoma who received it. Of the six who could be assessed, five saw their tumors fully respond and one partly responded, and no unexpected severe side effects occurred.

  • ProductFiscal.ai

    Alpha Tau Medical reports positive interim data from U.S. REGAIN trial in recurrent glioblastoma

    Alpha Tau Medical released positive interim results from its U.S. REGAIN trial, which is testing a treatment in patients with recurrent glioblastoma. The company did not disclose specific figures in the announcement.

  • NewsFiscal.ai

    Alpha Tau Medical to Host Call on REGAIN Trial Interim Results

    Alpha Tau Medical will hold a conference call to go over interim results from its REGAIN trial. The call gives the company a chance to walk through where the study stands so far.

All DRTS news from the last 90 days →
SEPT InvestingBeta Pioneer $29.99/mo until Jan 2, 2027

Live DRTS chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.

Start free 7-day trial

Frequently asked questions

Is DRTS bullish or bearish today?

DRTS daily trend: Downtrend (confirmed) — turns up above $14.5. SEPT signal: Expanding (Consolidating). Updated Nov 19, 2026.

What is DRTS's trend on each timeframe?

Daily: Downtrend (confirmed); 4 hour: Expanding; 1 hour: Strong Bearish; 15 min: Bullish; 5 min: Bullish.

What are DRTS support and resistance levels?

Support: $10.96, $9.21, $7.17. Resistance: $12.67, $13.56, $14.43. Last price $11.31.

Are insiders buying or selling DRTS?

Insider signal: Sell. Last 30 days: 0 buys, 0 sells. 98 hedge funds hold DRTS.

What is the latest news on DRTS?

Nov 16, 2026: Alpha Dart Therapy clears tumors in five brain cancer patients · Nov 16, 2026: Alpha Tau says Alpha DaRT worked in all eight brain cancer patients treated · Nov 15, 2026: Alpha Tau Medical reports positive interim data from U.S. REGAIN trial in recurrent glioblastoma